Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Extropy Ventures GmbH is a Berlin-based venture capital firm founded to focus on the science and infrastructure of healthy aging and human longevity. Established with the mission to make long-term investments, Extropy Ventures seeks to support companies that contribute to extending healthy human lifespan. The firm operates globally, with a particular emphasis on Europe, and is dedicated to fostering advancements in the biotech and healthcare sectors.
As of now, Extropy Ventures manages a portfolio that includes innovative companies in the longevity space. The firm is led by a small but focused team, with a commitment to identifying and nurturing early-stage ventures that align with their investment thesis. Their approach combines scientific rigor with a keen understanding of market dynamics, positioning them as a notable player in the longevity investment arena.
Extropy Ventures invests primarily in early-stage companies, specifically targeting pre-seed, Seed, Seed+, and Series A rounds. The firm is particularly interested in breakthroughs related to AI-driven drug discovery, epigenomics, and geroscience. Their investment strategy emphasizes the acceleration of advancements that can lead to longer and healthier lives, aligning with their overarching goal of supporting innovations in healthy aging.
Investment checks typically range from pre-seed to Series A, allowing Extropy Ventures to engage with startups at various stages of development. The firm’s geographic focus is global, with a strong presence in Europe, enabling them to tap into a diverse array of innovative companies in the biotech and healthcare sectors.
Extropy Ventures has a focused portfolio that includes the following company:
Manuel Loistl: Founder of Extropy Ventures, Manuel has a background in venture capital and a strong focus on the science of healthy aging. His expertise lies in identifying and supporting innovative companies that contribute to extending human lifespan.
Founders can pitch to Extropy Ventures through their website. It is advisable to include a detailed deck that outlines the business model, market opportunity, and alignment with the firm's focus on longevity. Response times may vary, but founders should expect to hear back within a few weeks.
Life Summit: This premier longevity event brings together global visionaries to shape the future of human health and longevity. The event serves as a platform for networking and collaboration among leaders in the field.
What are Extropy Ventures' investment criteria?
Extropy Ventures focuses on early-stage companies in the biotech and healthcare sectors, particularly those involved in AI-driven drug discovery, epigenomics, and geroscience. They look for innovative solutions that contribute to healthy aging and longevity.
How can I pitch to Extropy Ventures?
Founders can pitch their ideas through the Extropy Ventures website. It is recommended to include a clear outline of the business model, market potential, and how the startup aligns with the firm's focus on longevity and healthy aging.
What makes Extropy Ventures different from other investors?
Extropy Ventures distinguishes itself by concentrating specifically on the science of healthy aging and longevity. Their investment thesis is centered on long-term impacts, aiming to support breakthroughs that can significantly extend healthy human lifespan.
What is the geographic scope of Extropy Ventures?
The firm operates globally, with a strong emphasis on Europe. This allows them to engage with a diverse range of startups and innovations in the longevity sector.
What is the typical check size for investments?
Extropy Ventures invests in early-stage rounds, including pre-seed, Seed, Seed+, and Series A, with check sizes varying based on the stage and potential of the startup.
What kind of support do portfolio companies receive?
Extropy Ventures provides operational support and strategic guidance to its portfolio companies, leveraging their expertise in the longevity sector to help startups navigate challenges and scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.